Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus

Antonie Van Leeuwenhoek. 2017 Mar;110(3):347-355. doi: 10.1007/s10482-016-0806-2. Epub 2016 Dec 10.

Abstract

Phage lysins are considered promising antimicrobials against resistant bacterial infections. Some lysins have been reported for the prevention and treatment of Gram-positive bacterial infection. Gram-negative bacterial phage lysins, however, can only destroy the bacterial cell wall from inside because of the obstruction of the bacterial outer membrane that prevents direct hydrolysis of the bacterial wall peptidoglycan from the outside, severely restricting the development of lysins against Gram-negative bacteria. In this study, genetic engineering techniques were used to fuse a 5 cationic amino acid polypeptide (KRKRK), a 10 cationic amino acid polypeptide (KRKRKRKRKR), a 15 cationic amino acid polypeptide (KRKRKRKRKRKRKRK), and a polypeptide including both cationic and hydrophobic amino acids (KRKRKFFVAIIP) to the C-terminus of the Escherichia coli phage lysin Lysep3 to obtain four fusion lysins (5aa, 10aa, 15aa, Mix). The bactericidal effects of those four lysins on E. coli were then compared in vitro. Our results showed that the fusion of hydrophobic and positively charged amino acids, Mix, can kill E. coli effectively; the fusion of positively charged amino acids alone at the C-terminus (5aa, 10aa, 15aa) also showed bactericidal activity against E. coli from the outside, with the bactericidal activity gradually increasing with the positive charge at the C-terminus of the lysin. Collectively, improving the positive charge at the C-terminus of E. coli bacteriophage lysin Lysep3 increases its bactericidal ability from outside E. coli, providing a new practical method for the development of anti-Gram-negative bacterial lysins.

Keywords: Antimicrobial resistance; Bacteriophage; Bacteriophage lysins; Escherichia coli; Gram-negative bacteria; Superbugs.

MeSH terms

  • Amino Acid Sequence
  • Antimicrobial Cationic Peptides / genetics*
  • Antimicrobial Cationic Peptides / metabolism
  • Antimicrobial Cationic Peptides / pharmacology*
  • Bacteriolysis
  • Cell Wall / metabolism
  • Coliphages / genetics*
  • Coliphages / metabolism
  • DNA, Viral
  • Drug Synergism
  • Escherichia coli / drug effects*
  • Escherichia coli / virology
  • Genetic Engineering / methods
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / virology
  • Peptidoglycan / metabolism
  • Viral Proteins / genetics*
  • Viral Proteins / metabolism
  • Viral Proteins / pharmacology*

Substances

  • Antimicrobial Cationic Peptides
  • DNA, Viral
  • Peptidoglycan
  • Viral Proteins